SCHEMBL4368152

SCHEMBL4368152

CCC1CCC(CN)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4373236 0.90
SCHEMBL4374384 0.90 S1PR2 (0.32)
SCHEMBL2017258 0.86
SCHEMBL1763282 0.86
SCHEMBL13535333 0.86
SCHEMBL4369973 0.80 S1PR2 (0.38)
SCHEMBL13127200 0.75
SCHEMBL24577684 0.75 S1PR2 (0.42)
SCHEMBL8290708 0.75 CYP2C9 (0.38)
SCHEMBL1722167 0.75 CYP2C9 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738647-B2 Methods for the synthesis of polycyclic guanidine compounds SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-08-22 US disclosed
US-20140194622-A1 METHODS FOR THE SYNTHESIS OF POLYCYCLIC GUANIDINE COMPOUNDS NOVOMER, INC. (US) 2014-07-10 US disclosed
US-8642771-B2 Methods for the synthesis of polycyclic guanidine compounds NOVOMER, INC. (US) 2014-02-04 US disclosed
US-20120259112-A1 METHODS FOR THE SYNTHESIS OF POLYCYCLIC GUANIDINE COMPOUNDS NOVOMER, INC. (US) 2012-10-11 US disclosed
US-8212037-B2 Process for production of optically active quinuclidinols KANTO KAGAKU KABUSHIKI KAISHA (JP) 2012-07-03 US disclosed
US-20090216019-A1 Process for Production of Optically Active Quinuclidinols KANTO KAGAKU KABUSHIKI KAISHA 2009-08-27 US disclosed
EP-1867654-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE QUINUCLIDINOL Nagoya Industrial Science Research Institute (JP) 2007-12-19 EP disclosed
EP-1096931-A2 USE OF (S) (-)-AMISULPRIDE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SCHIZOPHRENIA SANOFI-SYNTHELABO (FR) 2001-05-09 EP disclosed
WO-2000003740-A2 USE OF (S) (-)-AMISULPRIDE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SCHIZOPHRENIA SANOFI-SYNTHELABO (FR) 2000-01-27 WO disclosed